Key Quantitative Figures
- Fine Amount: ₹2,360 (₹2,000 fine + ₹360 GST)
- Days of Delay: 1 day
- Fine per Day: ₹2,000 as per the standard operating procedure
Parties Involved
- Regulator: National Stock Exchange of India Limited (NSE)
- Listed Entity: Suraksha Diagnostic Limited (CIN: L85110WB2005PLC102265)
- Company Representatives: Ritu Mittal, Joint Managing Director & CEO (DIN: 00165886)
- NSE Representative: Sonam Yadav, Manager
- Promoters CC'd on NSE Notice: Satish Kumar Verma, Somnath Chatterjee, Ritu Mittal
Purpose / Rationale
The disclosure is made in compliance with the NSE's directive, as per SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 (Master Circular), to place the matter of non-compliance before the Board and communicate the Board's comments back to the Exchange.
Financial Impact
As per the details provided in the tabular format, the company states: "No impact on the financial operations or other activities of the Company." The fine of ₹2,360 has already been paid.
Board Comments & Remedial Measures
The Board of Directors, at its meeting on 14th October 2026, noted the non-compliance and the remedial measures undertaken. The Board was apprised that the secretarial team had taken steps to ensure timely compliance and avoid recurrence. The Board advised the secretarial team to exercise utmost care and diligence and emphasized the need to strengthen internal monitoring mechanisms and compliance controls. The company reaffirmed its commitment to maintaining high standards of corporate governance.
Context from Enclosed NSE Notice
The attached NSE notice (Annexure I) served as a final reminder before the freezing of promoter holdings. It stated that failure to pay the fine or achieve compliance within 10 days of the letter (dated 31st August 2026) would lead the Exchange to freeze the entire shareholding of the promoters. This action was avoided as the company paid the fine on 29th September 2026.
#Tags: #SurakshaDiagnostic #SEBIRegulation31 #SEBIDisclosure #RegulatoryCompliance #Neutral